HEADER    HYDROLASE                               14-MAR-05   2BMG              
TITLE     CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50                     
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: COAGULATION FACTOR X;                                      
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: LIGHT CHAIN, RESIDUES 126-178;                             
COMPND   5 SYNONYM: BLOOD COAGULATION FACTOR XA, STUART FACTOR, STUART-PROWER   
COMPND   6 FACTOR;                                                              
COMPND   7 EC: 3.4.21.6;                                                        
COMPND   8 MOL_ID: 2;                                                           
COMPND   9 MOLECULE: COAGULATION FACTOR X;                                      
COMPND  10 CHAIN: B;                                                            
COMPND  11 FRAGMENT: HEAVY CHAIN, RESIDUES 235-468;                             
COMPND  12 SYNONYM: BLOOD COAGULATION FACTOR XA, STUART FACTOR, STUART-PROWER   
COMPND  13 FACTOR;                                                              
COMPND  14 EC: 3.4.21.6                                                         
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 TISSUE: BLOOD;                                                       
SOURCE   6 MOL_ID: 2;                                                           
SOURCE   7 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   8 ORGANISM_COMMON: HUMAN;                                              
SOURCE   9 ORGANISM_TAXID: 9606;                                                
SOURCE  10 TISSUE: BLOOD                                                        
KEYWDS    THROMBOSIS, PROTEIN INHIBITOR COMPLEX, BLOOD COAGULATION FACTOR,      
KEYWDS   2 SERINE PROTEINASE, DRUG DESIGN, HYDROLASE                            
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    H.SCHREUDER,H.MATTER,D.W.WILL,M.NAZARE,V.LAUX,V.WEHNER,P.LOENZE,      
AUTHOR   2 A.LIESUM                                                             
REVDAT   6   20-NOV-24 2BMG    1       REMARK                                   
REVDAT   5   13-DEC-23 2BMG    1       LINK                                     
REVDAT   4   30-JAN-19 2BMG    1       REMARK                                   
REVDAT   3   28-JUN-17 2BMG    1       REMARK                                   
REVDAT   2   24-FEB-09 2BMG    1       VERSN                                    
REVDAT   1   08-MAR-06 2BMG    0                                                
JRNL        AUTH   H.MATTER,D.W.WILL,M.NAZARE,H.SCHREUDER,V.LAUX,V.WEHNER,      
JRNL        AUTH 2 A.LIESUM                                                     
JRNL        TITL   STRUCTURAL REQUIREMENTS FOR FACTOR XA INHIBITION BY          
JRNL        TITL 2 3-OXYBENZAMIDES WITH NEUTRAL P1 SUBSTITUENTS: COMBINING      
JRNL        TITL 3 X-RAY CRYSTALLOGRAPHY, 3D-QSAR AND TAILORED SCORING          
JRNL        TITL 4 FUNCTIONS                                                    
JRNL        REF    J.MED.CHEM.                   V.  48  3290 2005              
JRNL        REFN                   ISSN 0022-2623                               
JRNL        PMID   15857135                                                     
JRNL        DOI    10.1021/JM049187L                                            
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.70 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNX 2000                                             
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-              
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,              
REMARK   3               : READ,RICE,SIMONSON,WARREN,ACCELRYS                   
REMARK   3               : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA,            
REMARK   3               : YIP,DZAKULA)                                         
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 50.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : NULL                           
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : NULL                           
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : NULL                           
REMARK   3   NUMBER OF REFLECTIONS             : 9098                           
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : NULL                            
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.193                           
REMARK   3   R VALUE            (WORKING SET) : 0.193                           
REMARK   3   FREE R VALUE                     : 0.277                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 9.800                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 910                             
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : NULL                            
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL WITH ALL DATA.                               
REMARK   3   R VALUE     (WORKING + TEST SET, NO CUTOFF) : NULL                 
REMARK   3   R VALUE            (WORKING SET, NO CUTOFF) : NULL                 
REMARK   3   FREE R VALUE                    (NO CUTOFF) : NULL                 
REMARK   3   FREE R VALUE TEST SET SIZE   (%, NO CUTOFF) : NULL                 
REMARK   3   FREE R VALUE TEST SET COUNT     (NO CUTOFF) : NULL                 
REMARK   3   ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL                 
REMARK   3   TOTAL NUMBER OF REFLECTIONS     (NO CUTOFF) : NULL                 
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 18                           
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.70                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.75                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : NULL                         
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : NULL                         
REMARK   3   BIN R VALUE           (WORKING SET) : 0.4360                       
REMARK   3   BIN FREE R VALUE                    : 0.4766                       
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 11.10                        
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : NULL                         
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : NULL                         
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2249                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 36                                      
REMARK   3   SOLVENT ATOMS            : 218                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 20.40                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 26.70                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : -0.06800                                             
REMARK   3    B22 (A**2) : 0.12000                                              
REMARK   3    B33 (A**2) : -0.05200                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : NULL                            
REMARK   3   ESD FROM SIGMAA              (A) : NULL                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : NULL                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : NULL                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : NULL                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.009                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.332                           
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 24.80                           
REMARK   3   IMPROPER ANGLES        (DEGREES) : 0.860                           
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED                                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : 5.400 ; 1.500                
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 8.700 ; 2.000                
REMARK   3   SIDE-CHAIN BOND              (A**2) : 7.600 ; 2.000                
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 11.200; 2.500                
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED : BABINET                                              
REMARK   3   KSOL        : 0.33                                                 
REMARK   3   BSOL        : 39.13                                                
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : PROTEIN_REP.PARAM                              
REMARK   3  PARAMETER FILE  2  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : AVENTIS.TOP                                    
REMARK   3  TOPOLOGY FILE  2   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2BMG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-MAR-05.                  
REMARK 100 THE DEPOSITION ID IS D_1290023319.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 20-OCT-00                          
REMARK 200  TEMPERATURE           (KELVIN) : 100.0                              
REMARK 200  PH                             : 5.70                               
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : N                                  
REMARK 200  RADIATION SOURCE               : ROTATING ANODE                     
REMARK 200  BEAMLINE                       : NULL                               
REMARK 200  X-RAY GENERATOR MODEL          : ELLIOTT GX-13                      
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.5418                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : OSMIC MIRRORS                      
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : MARRESEARCH                        
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : XDS                                
REMARK 200  DATA SCALING SOFTWARE          : XSCALE                             
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 9120                               
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.700                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 50.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 98.0                               
REMARK 200  DATA REDUNDANCY                : 3.700                              
REMARK 200  R MERGE                    (I) : 0.09000                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 12.0000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.80                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 84.0                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 2.70                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.22000                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 5.400                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: CNX                                                   
REMARK 200 STARTING MODEL: PDB ENTRY 1LPG                                       
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 46.01                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG600, MES, CACL2, PH 5.7, VAPOR        
REMARK 280  DIFFUSION, HANGING DROP, TEMPERATURE 298.0K, PH 5.70                
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       28.50000            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       39.05000            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       36.15000            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       39.05000            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       28.50000            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       36.15000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PQS                                                   
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    LYS A  -2      -89.80   -101.63                                   
REMARK 500    LEU A  -1     -106.22    -86.12                                   
REMARK 500    GLN A  10     -122.61   -135.48                                   
REMARK 500    GLN A  16       90.42     67.81                                   
REMARK 500    ASN A  17       64.83     14.08                                   
REMARK 500    SER A  18      138.50   -172.62                                   
REMARK 500    ALA B  61A     140.52    179.92                                   
REMARK 500    THR B  73        9.35    -69.14                                   
REMARK 500    ARG B 115     -156.83   -170.04                                   
REMARK 500    PHE B 181      149.19   -172.14                                   
REMARK 500    ASP B 189      173.95    177.62                                   
REMARK 500    VAL B 213      109.91    -56.79                                   
REMARK 500    SER B 214      -69.28   -101.23                                   
REMARK 500    ALA B 221       13.25     58.81                                   
REMARK 500    PHE B 234       17.42   -140.68                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 620                                                                      
REMARK 620 METAL COORDINATION                                                   
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):                             
REMARK 620                                                                      
REMARK 620 COORDINATION ANGLES FOR:  M RES CSSEQI METAL                         
REMARK 620                              CA B1245  CA                            
REMARK 620 N RES CSSEQI ATOM                                                    
REMARK 620 1 ASP B  70   OD1                                                    
REMARK 620 2 ASN B  72   O    64.1                                              
REMARK 620 3 GLN B  75   O   116.9  84.3                                        
REMARK 620 4 GLU B  80   OE2  90.0 153.6 104.3                                  
REMARK 620 5 HOH B2034   O    72.6 106.9 168.2  67.5                            
REMARK 620 6 HOH B2036   O    63.8  70.0  54.2  94.5 132.7                      
REMARK 620 N                    1     2     3     4     5                       
REMARK 700                                                                      
REMARK 700 SHEET                                                                
REMARK 700 DETERMINATION METHOD: DSSP                                           
REMARK 700 THE SHEETS PRESENTED AS "BB" IN EACH CHAIN ON SHEET RECORDS          
REMARK 700 BELOW IS ACTUALLY AN  6-STRANDED BARREL THIS IS REPRESENTED BY       
REMARK 700 A  7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS              
REMARK 700 ARE IDENTICAL.                                                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B1245                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I1H B1246                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1C5M   RELATED DB: PDB                                   
REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING,    
REMARK 900 SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR    
REMARK 900 RELATED ID: 1EZQ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH      
REMARK 900 RPR128515                                                            
REMARK 900 RELATED ID: 1F0R   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH      
REMARK 900 RPR208815                                                            
REMARK 900 RELATED ID: 1F0S   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH      
REMARK 900 RPR208707                                                            
REMARK 900 RELATED ID: 1FAX   RELATED DB: PDB                                   
REMARK 900 COAGULATION FACTOR XA INHIBITOR COMPLEX                              
REMARK 900 RELATED ID: 1FJS   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED      
REMARK 900 WITH FACTOR XA                                                       
REMARK 900 RELATED ID: 1FXY   RELATED DB: PDB                                   
REMARK 900 COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG-  
REMARK 900 CHLOROMETHYLKETONE                                                   
REMARK 900 RELATED ID: 1G2L   RELATED DB: PDB                                   
REMARK 900 FACTOR XA INHIBITOR COMPLEX                                          
REMARK 900 RELATED ID: 1G2M   RELATED DB: PDB                                   
REMARK 900 FACTOR XA INHIBITOR COMPLEX                                          
REMARK 900 RELATED ID: 1HCG   RELATED DB: PDB                                   
REMARK 900 BLOOD COAGULATION FACTOR XA                                          
REMARK 900 RELATED ID: 1IOE   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532                    
REMARK 900 RELATED ID: 1IQE   RELATED DB: PDB                                   
REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590                     
REMARK 900 RELATED ID: 1IQF   RELATED DB: PDB                                   
REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165                     
REMARK 900 RELATED ID: 1IQG   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159                    
REMARK 900 RELATED ID: 1IQH   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143                    
REMARK 900 RELATED ID: 1IQI   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125                    
REMARK 900 RELATED ID: 1IQJ   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124                    
REMARK 900 RELATED ID: 1IQK   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113                    
REMARK 900 RELATED ID: 1IQL   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476                    
REMARK 900 RELATED ID: 1IQM   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471                    
REMARK 900 RELATED ID: 1IQN   RELATED DB: PDB                                   
REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192                     
REMARK 900 RELATED ID: 1KSN   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH       
REMARK 900 FXV673                                                               
REMARK 900 RELATED ID: 1KYE   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-     
REMARK 900 CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE                      
REMARK 900 RELATED ID: 1LPG   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79.                         
REMARK 900 RELATED ID: 1LPK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125.                        
REMARK 900 RELATED ID: 1LPZ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.                         
REMARK 900 RELATED ID: 1LQD   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.                         
REMARK 900 RELATED ID: 1MQ5   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)      
REMARK 900 AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2-        
REMARK 900 THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA                   
REMARK 900 RELATED ID: 1MQ6   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-          
REMARK 900 PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2-      
REMARK 900 OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH  
REMARK 900 HUMAN FACTOR XA                                                      
REMARK 900 RELATED ID: 1MSX   RELATED DB: PDB                                   
REMARK 900 HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-       
REMARK 900 METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-  
REMARK 900 4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR     
REMARK 900 AND MD SIMULATIONS.                                                  
REMARK 900 RELATED ID: 1NFU   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH       
REMARK 900 RPR132747                                                            
REMARK 900 RELATED ID: 1NFW   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH       
REMARK 900 RPR209685                                                            
REMARK 900 RELATED ID: 1NFX   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH       
REMARK 900 RPR208944                                                            
REMARK 900 RELATED ID: 1NFY   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH       
REMARK 900 RPR200095                                                            
REMARK 900 RELATED ID: 1NL8   RELATED DB: PDB                                   
REMARK 900 THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX 
REMARK 900 RELATED ID: 1P0S   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH      
REMARK 900 ECOTIN M84R                                                          
REMARK 900 RELATED ID: 1V3X   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-        
REMARK 900 TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-  
REMARK 900 CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE                                
REMARK 900 RELATED ID: 1WU1   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)     
REMARK 900 SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]   
REMARK 900 CARBONYL]PIPERAZINE                                                  
REMARK 900 RELATED ID: 1XKA   RELATED DB: PDB                                   
REMARK 900 FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-   
REMARK 900 AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID              
REMARK 900 RELATED ID: 1XKB   RELATED DB: PDB                                   
REMARK 900 FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-   
REMARK 900 AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID              
REMARK 900 RELATED ID: 2BOH   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1                     
REMARK 900 RELATED ID: 2BOK   RELATED DB: PDB                                   
REMARK 900 FACTOR XA - CATION                                                   
REMARK 900 RELATED ID: 2BQ6   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21                    
REMARK 900 RELATED ID: 2BQ7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43                    
REMARK 900 RELATED ID: 2BQW   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45           
DBREF  2BMG A   -3    50  UNP    P00742   FA10_HUMAN     126    178             
DBREF  2BMG B   16   244  UNP    P00742   FA10_HUMAN     235    468             
SEQRES   1 A   53  ARG LYS LEU CYS SER LEU ASP ASN GLY ASP CYS ASP GLN          
SEQRES   2 A   53  PHE CYS HIS GLU GLU GLN ASN SER VAL VAL CYS SER CYS          
SEQRES   3 A   53  ALA ARG GLY TYR THR LEU ALA ASP ASN GLY LYS ALA CYS          
SEQRES   4 A   53  ILE PRO THR GLY PRO TYR PRO CYS GLY LYS GLN THR LEU          
SEQRES   5 A   53  GLU                                                          
SEQRES   1 B  234  ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO          
SEQRES   2 B  234  TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE          
SEQRES   3 B  234  CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR          
SEQRES   4 B  234  ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL          
SEQRES   5 B  234  ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY          
SEQRES   6 B  234  GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN          
SEQRES   7 B  234  ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL          
SEQRES   8 B  234  LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL          
SEQRES   9 B  234  ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER          
SEQRES  10 B  234  THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE          
SEQRES  11 B  234  GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU          
SEQRES  12 B  234  LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS          
SEQRES  13 B  234  LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE          
SEQRES  14 B  234  CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN          
SEQRES  15 B  234  GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP          
SEQRES  16 B  234  THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY          
SEQRES  17 B  234  CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL          
SEQRES  18 B  234  THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR          
HET     CA  B1245       1                                                       
HET    I1H  B1246      35                                                       
HETNAM      CA CALCIUM ION                                                      
HETNAM     I1H 3-[2-(2,4-DICHLOROPHENYL)ETHOXY]-4-METHOXY-N-[(1-                
HETNAM   2 I1H  PYRIDIN-4-YLPIPERIDIN-4-YL)METHYL]BENZAMIDE                     
FORMUL   3   CA    CA 2+                                                        
FORMUL   4  I1H    C27 H29 CL2 N3 O3                                            
FORMUL   5  HOH   *218(H2 O)                                                    
HELIX    1   1 LEU A    3  CYS A    8  5                                   6    
HELIX    2   2 ALA B   55  GLN B   61  5                                   7    
HELIX    3   3 GLU B  124A LEU B  131A 1                                   9    
HELIX    4   4 ASP B  164  SER B  172  1                                   9    
HELIX    5   5 PHE B  234  THR B  244  1                                  11    
SHEET    1  AA 2 PHE A  11  GLU A  14  0                                        
SHEET    2  AA 2 VAL A  19  SER A  22 -1  O  VAL A  20   N  HIS A  13           
SHEET    1  AB 2 TYR A  27  LEU A  29  0                                        
SHEET    2  AB 2 CYS A  36  PRO A  38 -1  O  ILE A  37   N  THR A  28           
SHEET    1  BA 7 GLN B  20  GLU B  21  0                                        
SHEET    2  BA 7 LYS B 156  PRO B 161 -1  O  MET B 157   N  GLN B  20           
SHEET    3  BA 7 THR B 135  GLY B 140 -1  O  GLY B 136   N  VAL B 160           
SHEET    4  BA 7 PRO B 198  PHE B 203 -1  O  PRO B 198   N  SER B 139           
SHEET    5  BA 7 THR B 206  GLY B 216 -1  O  THR B 206   N  PHE B 203           
SHEET    6  BA 7 GLY B 226  LYS B 230 -1  O  ILE B 227   N  TRP B 215           
SHEET    7  BA 7 MET B 180  ALA B 183 -1  O  PHE B 181   N  TYR B 228           
SHEET    1  BB 7 GLN B  30  ASN B  35  0                                        
SHEET    2  BB 7 GLY B  40  ILE B  46 -1  N  PHE B  41   O  LEU B  33           
SHEET    3  BB 7 TYR B  51  THR B  54 -1  O  LEU B  53   N  THR B  45           
SHEET    4  BB 7 ALA B 104  LEU B 108 -1  O  ALA B 104   N  THR B  54           
SHEET    5  BB 7 ALA B  81  LYS B  90 -1  N  GLU B  86   O  ARG B 107           
SHEET    6  BB 7 PHE B  64  VAL B  68 -1  O  PHE B  64   N  VAL B  85           
SHEET    7  BB 7 GLN B  30  ASN B  35 -1  O  LEU B  32   N  ARG B  67           
SSBOND   1 CYS A    1    CYS A   12                          1555   1555  2.04  
SSBOND   2 CYS A    8    CYS A   21                          1555   1555  2.02  
SSBOND   3 CYS A   23    CYS A   36                          1555   1555  2.03  
SSBOND   4 CYS A   44    CYS B  122                          1555   1555  2.03  
SSBOND   5 CYS B   22    CYS B   27                          1555   1555  2.03  
SSBOND   6 CYS B   42    CYS B   58                          1555   1555  2.03  
SSBOND   7 CYS B  168    CYS B  182                          1555   1555  2.02  
SSBOND   8 CYS B  191    CYS B  220                          1555   1555  2.03  
LINK         OD1 ASP B  70                CA    CA B1245     1555   1555  2.79  
LINK         O   ASN B  72                CA    CA B1245     1555   1555  2.74  
LINK         O   GLN B  75                CA    CA B1245     1555   1555  2.90  
LINK         OE2 GLU B  80                CA    CA B1245     1555   1555  3.05  
LINK        CA    CA B1245                 O   HOH B2034     1555   1555  3.00  
LINK        CA    CA B1245                 O   HOH B2036     1555   1555  2.73  
SITE     1 AC1  7 ASP B  70  ASN B  72  GLN B  75  GLU B  77                    
SITE     2 AC1  7 GLU B  80  HOH B2034  HOH B2036                               
SITE     1 AC2 19 GLU B  97  THR B  98  TYR B  99  GLU B 147                    
SITE     2 AC2 19 PHE B 174  ASP B 189  ALA B 190  CYS B 191                    
SITE     3 AC2 19 GLN B 192  SER B 195  VAL B 213  SER B 214                    
SITE     4 AC2 19 TRP B 215  GLY B 216  GLY B 219  CYS B 220                    
SITE     5 AC2 19 GLY B 226  ILE B 227  TYR B 228                               
CRYST1   57.000   72.300   78.100  90.00  90.00  90.00 P 21 21 21    4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.017544  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.013831  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.012804        0.00000